Medical Journals

Slow Isomerization Step in the Interaction Between Mouse Dopamine Transporter and Dopamine Re-uptake Inhibitor N-(3-iodoprop-2e-enyl)-2beta-carbo-[3h]methoxy-3beta-(4'-methylphenyl)nortropane.

Authors:
  • Stepanov Vladimir
  • Järv Jaak

From: Institute of Organic and Bioorganic Chemistry, University of Tartu, 2 Jakobi Str, 51014 Tartu, Estonia.

Neuroscience letters

  • Publish Date: Dec 2006
  • ISSN: 0304-3940
  • Volume: 410
  • Issue: 3
  • Pages: 218-21
  • Medium: Print
  • Language: English
  • Citation (JAMA): Stepanov Vladimir, Järv Jaak, et al. Slow Isomerization Step in the Interaction Between Mouse Dopamine Transporter and Dopamine Re-uptake Inhibitor N-(3-iodoprop-2e-enyl)-2beta-carbo-[3h]methoxy-3beta-(4'-methylphenyl)nortropane.. Neurosci. Lett. Dec 2006;410:218-21

Abstract

The kinetics of the association and dissociation of the tritium-labeled selective and potent dopamine transporter inhibitor N-(3-iodoprop-2E-enyl)-2beta-carbo-[3H]methoxy-3beta-(4’-methylphenyl)nortropane ([3H]PE2I) with the transporter of mouse striatal membranes was studied. The analysis revealed that the specific binding of [3H]PE2I occurs within a homogeneous population of binding sites in these membranes. The relatively slow binding process was characterized by the pseudo-first-order rate constant kobs. The plot of these rate constants versus free radioligand concentration was hyperbolic, demonstrating that at least two kinetically distinguishable steps can be identified in the interaction of dopamine transporter with this inhibitor. The fast and reversible binding step, characterized by dissociation constant KA = 51 +/- 23 nM, is followed by a slow but also reversible isomerization step of the complex, characterized by the isomerization rate constant ki = (7 +/- 2)10(-2) s(-1) and by the rate constant k(-i) = (3.9 +/- 0.5)10(-3) s(-1) for the reverse process. This isomerization step increases the apparent affinity of the ligand and probably consists of a conformational transition of the transporter protein, induced by the inhibitor molecule.

Mesh Headings (Keywords): Animals, Corpus Striatum, Dopamine Plasma Membrane Transport Proteins, Dopamine Uptake Inhibitors, Dose-Response Relationship, Drug, Drug Interactions, Male, Mice, Nortropanes, Protein Binding, Tritium


Check for Full Text / PubMed Unique Identifier (PMID): 17074440


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.